Skip to content

Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards.

Share
Copied link to clipboard!

Upperton Pharma Solutions (Upperton) Wins Integrated Manufacturing Award at the 2025 Pharmaceutical Technology Excellence Awards.

  • Upperton, UK-based CDMO (Contract, Development & Manufacturing Organisation) recognised as winner in the Integrated Manufacturing (Business Expansion) category at the 2025 Pharmaceutical Technology Excellence Awards.
  • Award follows the build of a 50,000 sq. ft development and manufacturing facility for oral, nasal and pulmonary dosage forms, alongside a 7,000 sq. ft sterile manufacturing facility built against revised EU GMP Annex-1 regulations.
  • CEO, Nikki Whitfield said: “Being recognised as an Excellence Award winner is a great achievement and highlights the hard work of all of our team over the past few years. This award recognises the vision we had when embarking on a new facility, and expansion into sterile manufacturing”.

To read the full article, visit: https://upperton.com/upperton-pharma-solutions-wins-business-expansion-award-at-the-2025-pharmaceutical-technology-excellence-awards/